DK2252688T3 - Syntetiske phosphodiester-oligonukleotider og terapeutiske anvendelser deraf - Google Patents
Syntetiske phosphodiester-oligonukleotider og terapeutiske anvendelser derafInfo
- Publication number
- DK2252688T3 DK2252688T3 DK09721382.1T DK09721382T DK2252688T3 DK 2252688 T3 DK2252688 T3 DK 2252688T3 DK 09721382 T DK09721382 T DK 09721382T DK 2252688 T3 DK2252688 T3 DK 2252688T3
- Authority
- DK
- Denmark
- Prior art keywords
- phosphodiests
- oligonucleotides
- synthetic
- therapeutic applications
- therapeutic
- Prior art date
Links
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 title 1
- 230000001225 therapeutic effect Effects 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/117—Nucleic acids having immunomodulatory properties, e.g. containing CpG-motifs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7088—Compounds having three or more nucleosides or nucleotides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/10—Type of nucleic acid
- C12N2310/17—Immunomodulatory nucleic acids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2320/00—Applications; Uses
- C12N2320/30—Special therapeutic applications
- C12N2320/31—Combination therapy
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Biomedical Technology (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Molecular Biology (AREA)
- Zoology (AREA)
- Biotechnology (AREA)
- Wood Science & Technology (AREA)
- General Engineering & Computer Science (AREA)
- Heart & Thoracic Surgery (AREA)
- Hematology (AREA)
- Physics & Mathematics (AREA)
- Immunology (AREA)
- Plant Pathology (AREA)
- Microbiology (AREA)
- Cardiology (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Diabetes (AREA)
- Epidemiology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP08425175A EP2103689A1 (en) | 2008-03-19 | 2008-03-19 | Synthetic phosphodiester oligonucleotides and therapeutical uses thereof |
| US5108808P | 2008-05-07 | 2008-05-07 | |
| PCT/EP2009/053002 WO2009115465A1 (en) | 2008-03-19 | 2009-03-13 | Synthetic phosphodiester oligonucleotides and therapeutical uses thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK2252688T3 true DK2252688T3 (da) | 2017-11-13 |
Family
ID=39683815
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK09721382.1T DK2252688T3 (da) | 2008-03-19 | 2009-03-13 | Syntetiske phosphodiester-oligonukleotider og terapeutiske anvendelser deraf |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20110092576A1 (enExample) |
| EP (2) | EP2103689A1 (enExample) |
| JP (1) | JP2011515357A (enExample) |
| KR (1) | KR20100124820A (enExample) |
| CN (2) | CN101978059A (enExample) |
| AU (1) | AU2009226906B2 (enExample) |
| CA (1) | CA2712705C (enExample) |
| DK (1) | DK2252688T3 (enExample) |
| ES (1) | ES2647772T3 (enExample) |
| IL (1) | IL207032A (enExample) |
| WO (1) | WO2009115465A1 (enExample) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103260627A (zh) | 2010-11-12 | 2013-08-21 | 真蒂奥姆有限公司 | 去纤维蛋白多核苷酸用于预防和/或治疗移植物抗宿主病(gvhd) |
| AU2012383169B2 (en) | 2012-06-22 | 2017-12-21 | Gentium S.R.L. | Euglobulin-based method for determining the biological activity of defibrotide |
| EP3026122A1 (en) | 2014-11-27 | 2016-06-01 | Gentium S.p.A. | Cellular-based method for determining the potency of defibrotide |
| SG11202000952PA (en) | 2017-08-03 | 2020-02-27 | Jazz Pharmaceuticals Ireland Ltd | Formulations comprising a nucleic acid in a high concentration |
| KR20210008478A (ko) | 2018-04-12 | 2021-01-22 | 재즈 파마슈티칼즈, 인코포레이티드 | 면역고갈과 관련된 사이토카인 방출 증후군 및 신경독성의 예방 및 치료를 위한 데피브로타이드 |
| US20220023533A1 (en) | 2018-12-07 | 2022-01-27 | Jazz Phrmaceticals Ireland Limited | Subcutaneous delivery of high concentration formulations |
| EP4110287A1 (en) | 2020-02-28 | 2023-01-04 | Jazz Pharmaceuticals Ireland Limited | Delivery of low viscosity formulations |
| WO2021212055A1 (en) | 2020-04-17 | 2021-10-21 | Jazz Pharmaceuticals Ireland Limited | Defibrotide treatment for the prevention of organ rejection and injury |
| TW202308659A (zh) | 2021-05-06 | 2023-03-01 | 愛爾蘭商爵士製藥愛爾蘭有限責任公司 | 用於急性呼吸窘迫症候群之治療及預防的去纖維蛋白多核苷酸 |
Family Cites Families (41)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US1325962A (en) * | 1919-12-23 | Geared lifting-jack | ||
| US2006A (en) * | 1841-03-16 | Clamp for crimping leather | ||
| US178761A (en) * | 1876-06-13 | Improvement in refrigerating-cans | ||
| US876235A (en) * | 1904-11-07 | 1908-01-07 | Leonard G Quackenboss | Adjustable flower-box. |
| US1276497A (en) * | 1917-07-18 | 1918-08-20 | Wencel H Kirchman | Dirigible balloon. |
| IT1043823B (it) | 1970-11-03 | 1980-02-29 | Prephar | Procedimento per l estrazione di acidi nucleici da organi animali |
| DE2154279A1 (de) | 1970-11-03 | 1972-05-25 | Crinos Industria Farmaco | Medikamente für das fibrinolytische System |
| US3899481A (en) | 1970-11-03 | 1975-08-12 | Crinos Industria Farmaco | Process for the controlled partial degradation of deoxyribonucleic acid extracted from animal organs |
| US4853221A (en) * | 1980-11-13 | 1989-08-01 | Warner-Lambert Company | Method for treating non-small cell lung cancer, head and neck cancers and breast cancer |
| IT1170215B (it) * | 1983-09-12 | 1987-06-03 | Crinos Industria Farmaco | Composizione farmaceutica per il trattamento di stati di insufficienza renale acuta |
| IT1170214B (it) | 1983-09-12 | 1987-06-03 | Crinos Industria Farmaco | Composizione farmaceutica per la cura delle arteriopatie periferiche |
| IT1206341B (it) | 1984-02-16 | 1989-04-14 | Crinos Industria Farmaco | Composizione farmaceutica per il trattamento dell'ischemia acuta del miocardio. |
| US4694134A (en) | 1985-05-28 | 1987-09-15 | Ajax Magnethermic Corporation | Apparatus for overheating edges of skelp for the production of compression welded pipe |
| IT1190313B (it) * | 1986-04-17 | 1988-02-16 | Crinos Industria Farmaco | Procedimento per l'ottenimento di polidesossiribonucleotidi chimicamente definiti e riproducibili e prodotto farmacologicamente attivo risultante |
| US5223609A (en) | 1986-04-17 | 1993-06-29 | Crinos Industria Farmacobiologica S.P.A. | Process for obtaining chemically defined and reproducible polydeoxyribonucleotides |
| US4753221A (en) * | 1986-10-22 | 1988-06-28 | Intravascular Surgical Instruments, Inc. | Blood pumping catheter and method of use |
| IT1231509B (it) | 1989-09-07 | 1991-12-07 | Crinos Industria Farmaco | Composizione farmceutica ad uso topico per la terapia della fragilita' capillare. |
| US5166617A (en) * | 1991-01-11 | 1992-11-24 | Varian Associates, Inc. | High power NMR probe |
| US5977083A (en) | 1991-08-21 | 1999-11-02 | Burcoglu; Arsinur | Method for using polynucleotides, oligonucleotides and derivatives thereof to treat various disease states |
| US5624912A (en) | 1991-08-21 | 1997-04-29 | Burcoglu; Arsinur | Method of treating HIV infection and related secondary infections with defibrotide |
| US6699985B2 (en) | 1991-08-21 | 2004-03-02 | Arsinur Burcoglu | Method of treating HIV infection and related secondary infections thereof |
| IT1252174B (it) * | 1991-12-09 | 1995-06-05 | Crinos Industria Farmaco | Oligodesossimibonucleotidi ad attivita' antiischemica e procedimenti per il loro ottenimento |
| US5578716A (en) * | 1993-12-01 | 1996-11-26 | Mcgill University | DNA methyltransferase antisense oligonucleotides |
| WO1996016987A1 (en) * | 1994-11-30 | 1996-06-06 | Chugai Seiyaku Kabushiki Kaisha | Thrombocytotic factor |
| US6573372B2 (en) * | 1999-01-07 | 2003-06-03 | Heska Corporation | Feline immunoglobulin E molecules and compositions there of |
| ES2251134T3 (es) * | 1999-06-08 | 2006-04-16 | Gentium S.P.A. | Uso de complejos entre liposomas cationicos y polidesoxirribonucleotidos como medicamentos. |
| EP1147777A1 (en) | 2000-04-18 | 2001-10-24 | Crinos Industria Farmacobiologica S.p.A. | Combination of defibrotide and G-CSF and its use to activate haematopoietic progenitors |
| DE10046547A1 (de) | 2000-09-19 | 2002-03-28 | Innovat Ges Fuer Sondermaschb | Vorrichtung zum induktiven Aufheizen von Werkstücken |
| EP1334113A4 (en) * | 2000-10-20 | 2007-08-08 | Expression Diagnostics Inc | EVALUATION OF LEUCOCYTAIRE EXPRESSION LEVEL |
| US7235358B2 (en) * | 2001-06-08 | 2007-06-26 | Expression Diagnostics, Inc. | Methods and compositions for diagnosing and monitoring transplant rejection |
| WO2003027313A2 (en) * | 2001-09-24 | 2003-04-03 | The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | SUPPRESSORS OF CpG OLIGONUCLEOTIDES AND METHODS OF USE |
| US6965025B2 (en) * | 2001-12-10 | 2005-11-15 | Isis Pharmaceuticals, Inc. | Antisense modulation of connective tissue growth factor expression |
| EP1325962A1 (en) * | 2001-12-17 | 2003-07-09 | Gentium S.p.A. | A method for determining the biological activity of defibrotide |
| US20050215498A1 (en) * | 2002-05-31 | 2005-09-29 | Guenther Eissner | Method for the protection of endothelial and epithclial cells during chemotherapy |
| US20050196382A1 (en) * | 2002-09-13 | 2005-09-08 | Replicor, Inc. | Antiviral oligonucleotides targeting viral families |
| US7301265B2 (en) * | 2003-05-22 | 2007-11-27 | Seiko Epson Corporation | Light source unit, method of manufacturing light source unit, and projector |
| ITMI20031714A1 (it) | 2003-09-05 | 2005-03-06 | Gentium Spa | Formazioni ad azione antitumorale. |
| US7138558B2 (en) * | 2004-11-01 | 2006-11-21 | Uop Llc | Direct return of oxygenate recycle stream in olefin production process |
| CA2598613A1 (en) * | 2005-03-03 | 2006-09-14 | Gentium S.P.A. | Defibrotide and/or oligodeoxyribonucleotides for treating angiogenesis-dependent tumors |
| WO2006119619A1 (en) * | 2005-05-06 | 2006-11-16 | Replicor Inc. | Oligonucleotides inhibiting cell proliferation |
| GB2462413B (en) * | 2008-08-04 | 2011-03-02 | Rolls Royce Plc | An actuator arrangement |
-
2008
- 2008-03-19 EP EP08425175A patent/EP2103689A1/en not_active Withdrawn
-
2009
- 2009-03-13 AU AU2009226906A patent/AU2009226906B2/en not_active Ceased
- 2009-03-13 ES ES09721382.1T patent/ES2647772T3/es active Active
- 2009-03-13 JP JP2011500164A patent/JP2011515357A/ja active Pending
- 2009-03-13 EP EP09721382.1A patent/EP2252688B1/en active Active
- 2009-03-13 WO PCT/EP2009/053002 patent/WO2009115465A1/en not_active Ceased
- 2009-03-13 CN CN2009801097251A patent/CN101978059A/zh active Pending
- 2009-03-13 KR KR1020107023194A patent/KR20100124820A/ko not_active Ceased
- 2009-03-13 DK DK09721382.1T patent/DK2252688T3/da active
- 2009-03-13 CN CN201610647404.9A patent/CN106361763A/zh active Pending
- 2009-03-13 US US12/919,605 patent/US20110092576A1/en not_active Abandoned
- 2009-03-13 CA CA2712705A patent/CA2712705C/en active Active
-
2010
- 2010-07-15 IL IL207032A patent/IL207032A/en active IP Right Grant
Also Published As
| Publication number | Publication date |
|---|---|
| CN106361763A (zh) | 2017-02-01 |
| AU2009226906A1 (en) | 2009-09-24 |
| KR20100124820A (ko) | 2010-11-29 |
| ES2647772T3 (es) | 2017-12-26 |
| IL207032A0 (en) | 2010-12-30 |
| IL207032A (en) | 2016-08-31 |
| CN101978059A (zh) | 2011-02-16 |
| EP2252688A1 (en) | 2010-11-24 |
| EP2252688B1 (en) | 2017-08-16 |
| AU2009226906B2 (en) | 2015-05-07 |
| JP2011515357A (ja) | 2011-05-19 |
| CA2712705A1 (en) | 2009-09-24 |
| EP2103689A1 (en) | 2009-09-23 |
| WO2009115465A1 (en) | 2009-09-24 |
| US20110092576A1 (en) | 2011-04-21 |
| CA2712705C (en) | 2017-08-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK3338790T3 (da) | Oligopeptid-forbindelser og anvendelser deraf | |
| NL300891I2 (nl) | Lotilaner en zouten daarvan | |
| DK2185164T3 (da) | Sammensætning og terapeutisk antitumorvaccine | |
| DK2281006T3 (da) | Tværbindingsmidler og anvendelser deraf | |
| BRPI0907231A2 (pt) | pirrolpirimidinas e pirrolpiridinas | |
| CY2015013I1 (el) | Αντι-μολυσματικες πυραμιδινες και χρησεις αυτων | |
| DK3292874T3 (da) | Anti-mesothelin-immunkonjugater og anvendelser deraf | |
| DK2170827T3 (da) | Indolin-2-oner og aza-indolin-2-oner | |
| DK2185552T3 (da) | Dipeptoid-prodrugs og anvendelse heraf | |
| DK2118140T3 (da) | Humancytomegalovirus-neutraliserende antistoffer og anvendelse deraf | |
| DK2544719T3 (da) | Cd37-bindingsmolekyler og immunkonjugater deraf | |
| DK2209806T3 (da) | Anti-hepcidin-antistoffer og anvendelser deraf | |
| HRP20160737T1 (hr) | Anti-her3-protutijela i njihove uporabe | |
| BRPI0813647A2 (pt) | Piperazinil oxoalquil tetrahidro-beta-carbolinas e análogos relacionados | |
| BRPI0922486A2 (pt) | microcápsulas e suas respectivas utilizações | |
| HRP20170963T1 (hr) | Modificirani saharidi | |
| EP2122054A4 (en) | NONWOVEN PANEL AND PRODUCTION METHOD THEREOF | |
| DK2552434T3 (da) | Peptider og anvendelse deraf | |
| FI20075881L (fi) | Lääketieteellinen väline ja sen valmistus | |
| DK2805746T3 (da) | Alkylamido-forbindelser og anvendelser deraf | |
| DK2352509T3 (da) | Hla-g-proteiner og farmaceutiske anvendelser deraf | |
| DK2328931T3 (da) | Selektive anti-hepcidin-25-antistoffer og anvendelser deraf | |
| DK2001556T3 (da) | Thioninium-forbindelser og anvendelse deraf | |
| BRPI0816789A2 (pt) | Goji e inflamação | |
| DK2086213T3 (da) | Billedlæseapparat og billeddannelseapparat |